MIRA INFORM REPORT
|
Report Date : |
01.10.2011 |
IDENTIFICATION DETAILS
|
Name : |
TAIWAN VETERANS PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
No.447, Sec. 3, Jhongshan E. Rd., Jhongli City, Taoyuan County 320 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
21.12.2005 |
|
|
|
|
Com. Reg. No.: |
28059706 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sales of medicine |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 80,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Contact
Points
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.447, Sec. 3,
Jhongshan E. Rd., Jhongli City, Taoyuan County 320, Taiwan (R.O.C.) |
|
Supplied Address: |
447 Chung Shan East Rd., Section 3, Chungli, Citytaoyuan Hsien 320,
Taiwan |
|
Telephone Number: |
+886-3-4651190 |
|
Fax Number: |
Credit
Summary
|
Credit Rating: |
|
|
Credit Opinion: |
Company
Identification Details
|
Registered Name: |
Taiwan Veterans
Pharmaceutical Co., Ltd. |
|
Registered Address: |
No.447, Sec. 3,
Jhongshan E. Rd., Jhongli City, Taoyuan County 320, Taiwan (R.O.C.) |
|
Date of Foundation: |
|
|
Registration Number: |
|
|
Registry: |
Department of
Commerce, Ministry of Economic Affairs, R.O.C. |
|
Registered Capital: |
NTD 320,000,000 (USD 11,040,000) (As of 2011.09,
1 NTD = 0.0345 USD) |
|
Paid-up Capital: |
NTD 320,000,000
(USD 11,040,000) |
|
Legal Representatives: |
|
|
Legal Form: |
|
|
Principal Activities: |
|
|
Staff: |
|
|
Listed at Stock
Exchange: |
|
|
Date of Last
Annual Return: |
History
Subject was incorporated on 2005-12-21 with registered
number 28059706 as Private
Limited Liability Company in Taiwan.
Shareholders
|
Name |
Subscription Shares |
|
Xindong Bio-Tec Corporation |
17,280,000 |
|
Xing Zheng Yuan Guo Jun |
|
|
12,800,000 |
|
Notes: The information above is that of subject’s
major shareholders.
Subsidiaries &
Branches
Personnel
Information
Core
Management
|
1 |
|
|
Name |
Changqi Ke |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Yanhui Ke |
|
Position |
Director |
|
3 |
|
|
Name |
Xieji Huang |
|
Position |
Director |
|
4 |
|
|
Name |
Shouxiong Bai |
|
Position |
Director |
|
5 |
|
|
Name |
Changhui Ke |
|
Position |
|
|
6 |
|
|
Name |
Mingxun Liu |
|
Position |
Director |
|
7 |
|
|
Name |
Tianxiong Chen |
|
Position |
Director |
|
8 |
|
|
Name |
Defang Wang |
|
Position |
Director |
|
9 |
|
|
Name |
|
|
Position |
Director |
|
10 |
|
|
Name |
Kaiping Wang |
|
Position |
Director |
|
11 |
|
|
Name |
Jianxing Xie |
|
Position |
|
|
12 |
|
|
Name |
Minde Su |
|
Position |
|
|
13 |
|
|
Name |
Yahui Zhuang |
|
Position |
Auditor |
Personnel
Structure
|
Total Employees |
More than 10 Employees |
Operation
Information
Offices
& Factories
|
|
Headquarters |
|
Add |
No.447, Sec. 3, Jhongshan E. Rd., Jhongli City, Taoyuan County 320,
Taiwan (R.O.C.) |
Production
Information
l
The subject produces medicine.
l
The subject produces in Taiwan.
Purchase
Information
l
The raw material for production is mostly
purchased from domestic markets.
l
The subject is mainly engaged in sales of medicine.
l
The subject sells around the world.
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Settlements
Purchase
Domestic Purchase (Taiwan and Mainland, China)
|
Payment Terms |
Proportion |
|
|
Raw material |
COD, etc |
100% |
Foreign Purchase
Sales
Domestic Markets (Taiwan)
|
Sales Terms |
Proportion |
|
|
CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Medicine |
CBD, etc |
100% |
Financial
Information
|
Sales |
|
|
2010 |
About USD 8,000,000 |
Notes: We obtain the information
of subject from public files which is not confirmed by subject.
Bankers
|
Name |
Public
Record
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of reporting,
no existing or latent litigation of the subject has been found.
Interview
Details
|
Name |
Guoqiang Wang |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.48.93 |
|
UK Pound |
1 |
Rs.76.52 |
|
Euro |
1 |
Rs.66.65 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.